Jeremy Kinder

Jeremy Kinder, PhD is currently working as Director of T Cell Therapeutics at Sana Biotechnology, Inc. Their vast experience includes roles such as Principal Scientist and Senior Scientist within the same company. Prior to this, Jeremy served as an Independent Consultant providing technical expertise in life science. Jeremy also worked as a Research Associate at Cincinnati Children's Hospital Medical Center, where Jeremy focused on strengthening expertise in cytometric and next-generation sequencing techniques. Jeremy holds a PhD in Immunobiology from the University of Cincinnati College of Medicine, along with a Master of Science in Biology from Ball State University.